Integra LifeSciences (IART) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Integra LifeSciences Revenue Highlights


Latest Revenue (Y)

$1.54B

Latest Revenue (Q)

$418.18M

Main Segment (Y)

Codman Specialty Surgical

Main Geography (Y)

UNITED STATES

Integra LifeSciences Revenue by Period


Integra LifeSciences Revenue by Year

DateRevenueChange
2023-12-31$1.54B-1.03%
2022-12-31$1.56B0.99%
2021-12-31$1.54B12.43%
2020-12-31$1.37B-9.60%
2019-12-31$1.52B3.06%
2018-12-31$1.47B23.92%
2017-12-31$1.19B19.77%
2016-12-31$992.08M12.39%
2015-12-31$882.73M-4.91%
2014-12-31$928.30M11.01%
2013-12-31$836.21M0.64%
2012-12-31$830.87M6.51%
2011-12-31$780.08M6.56%
2010-12-31$732.07M7.26%
2009-12-31$682.49M4.26%
2008-12-31$654.60M18.92%
2007-12-31$550.46M31.28%
2006-12-31$419.30M50.86%
2005-12-31$277.94M20.93%
2004-12-31$229.82M23.83%
2003-12-31$185.60M64.79%
2002-12-31$112.63M20.53%
2001-12-31$93.44M43.79%
2000-12-31$64.99M52.91%
1999-12-31$42.50M142.86%
1998-12-31$17.50M19.05%
1997-12-31$14.70M12.21%
1996-12-31$13.10M28.43%
1995-12-31$10.20M-

Integra LifeSciences generated $1.54B in revenue during NA 2023, up -1.03% compared to the previous quarter, and up 104.70% compared to the same period a year ago.

Integra LifeSciences Revenue by Quarter

DateRevenueChange
2024-06-30$418.18M13.37%
2024-03-31$368.87M-7.09%
2023-12-31$397.04M3.82%
2023-09-30$382.42M0.30%
2023-06-30$381.27M0.11%
2023-03-31$380.85M-4.32%
2022-12-31$398.02M3.33%
2022-09-30$385.19M-3.17%
2022-06-30$397.81M5.62%
2022-03-31$376.64M-7.12%
2021-12-31$405.52M4.82%
2021-09-30$386.86M-0.80%
2021-06-30$389.99M8.31%
2021-03-31$360.07M-7.35%
2020-12-31$388.65M4.97%
2020-09-30$370.23M43.13%
2020-06-30$258.67M-27.00%
2020-03-31$354.32M-10.33%
2019-12-31$395.13M4.23%
2019-09-30$379.10M-1.19%
2019-06-30$383.64M6.66%
2019-03-31$359.69M-6.16%
2018-12-31$383.31M4.77%
2018-09-30$365.85M-0.09%
2018-06-30$366.19M2.55%
2018-03-31$357.08M-3.13%
2017-12-31$368.60M32.19%
2017-09-30$278.83M-1.18%
2017-06-30$282.16M9.10%
2017-03-31$258.64M1.16%
2016-12-31$255.66M2.13%
2016-09-30$250.33M0.41%
2016-06-30$249.31M5.30%
2016-03-31$236.77M-1.82%
2015-12-31$241.16M6.53%
2015-09-30$226.37M-7.26%
2015-06-30$244.08M4.46%
2015-03-31$233.66M-7.34%
2014-12-31$252.18M9.78%
2014-09-30$229.72M-0.71%
2014-06-30$231.35M7.58%
2014-03-31$215.06M-2.59%
2013-12-31$220.77M3.53%
2013-09-30$213.25M3.75%
2013-06-30$205.55M4.52%
2013-03-31$196.65M-8.29%
2012-12-31$214.43M2.07%
2012-09-30$210.08M-0.04%
2012-06-30$210.17M7.13%
2012-03-31$196.19M-3.61%
2011-12-31$203.52M0.66%
2011-09-30$202.19M4.58%
2011-06-30$193.33M6.79%
2011-03-31$181.04M-6.74%
2010-12-31$194.13M4.01%
2010-09-30$186.64M4.51%
2010-06-30$178.59M3.41%
2010-03-31$172.70M-5.90%
2009-12-31$183.53M6.52%
2009-09-30$172.29M3.96%
2009-06-30$165.72M2.97%
2009-03-31$160.95M-7.70%
2008-12-31$174.37M4.40%
2008-09-30$167.03M6.25%
2008-06-30$157.20M0.76%
2008-03-31$156.01M-1.04%
2007-12-31$157.65M-

Integra LifeSciences generated $418.18M in revenue during Q2 2024, up 13.37% compared to the previous quarter, and up 109.80% compared to the same period a year ago.

Integra LifeSciences Revenue Breakdown


Integra LifeSciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21Dec 20Dec 19Dec 18
Tissue Technologies$538.10M$517.22M---
Codman Specialty Surgical$1.02B$1.03B$894.83M$996.21M$963.93M
Orthopedics and Tissue Technologies--$477.04M$521.35M$508.51M

Integra LifeSciences's latest annual revenue breakdown by segment (product or service), as of Dec 22: Codman Specialty Surgical (65.45%), and Tissue Technologies (34.55%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Tissue Technologies$116.41M$112.44M$114.22M$110.24M$132.71M$133.43M$135.40M$139.95M$129.33M$134.87M$130.36M$133.16M$118.83M-------
Codman Specialty Surgical$301.76M$256.43M$268.20M$271.03M$248.14M$264.60M$249.80M$257.86M$247.31M$270.66M$256.50M$256.84M$241.24M$254.29M$239.32M$169.78M$231.44M$259.40M$252.98M$249.26M
Orthopedics and Tissue Technologies-------------$134.36M$130.91M$88.89M$122.88M$135.73M$126.11M$134.39M

Integra LifeSciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Codman Specialty Surgical (72.16%), and Tissue Technologies (27.84%).

Integra LifeSciences Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Dec 21Dec 20Dec 19Dec 18
Rest Of World$83.48M$79.56M$70.03M$85.32M$80.95M
Europe$170.90M$191.33M$172.69M$197.47M$201.35M
Asia Pacific$176.48M$182.03M$157.17M$157.39M$144.25M
UNITED STATES$1.13B$1.09B$971.98M$1.08B$1.05B

Integra LifeSciences's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (72.34%), Asia Pacific (11.33%), Europe (10.97%), and Rest Of World (5.36%).

Quarterly Revenue by Country

CountryJun 24Mar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Rest Of World$21.31M$21.50M$22.28M$19.33M$18.31M$19.31M$22.10M$20.24M$21.83M$21.72M$19.61M$19.06M$19.16M$19.84M$17.29M$11.29M$21.62M$22.85M$21.49M$22.35M
UNITED STATES$310.23M$256.23M$269.84M$276.78M$271.00M$294.10M$282.02M$287.35M$263.35M$287.77M$275.77M$278.19M$247.79M$276.80M$266.48M$181.85M$246.85M$280.98M$266.28M$273.39M
Europe$40.69M$41.60M$41.52M$37.45M$41.06M$42.00M$38.30M$46.86M$43.74M$50.61M$46.46M$48.44M$45.82M$48.77M$45.99M$32.03M$45.90M$48.72M$49.24M$50.87M
Asia Pacific$45.95M$49.55M$48.78M$47.71M$50.47M$42.62M$42.77M$43.37M$47.72M$45.42M$45.02M$44.31M$47.30M$43.24M$40.47M$33.50M$39.96M$42.58M$42.08M$37.03M

Integra LifeSciences's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (74.19%), Asia Pacific (10.99%), Europe (9.73%), and Rest Of World (5.10%).

Integra LifeSciences Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
ICUIICU Medical$2.26B$596.46M
IARTIntegra LifeSciences$1.54B$418.18M
HAEHaemonetics$1.31B$336.17M
MMSIMerit Medical Systems$1.26B$339.85M
CNMDCONMED$1.24B$316.70M

IART Revenue FAQ


Integra LifeSciences's yearly revenue for 2023 was $1.54B, representing a decrease of -1.03% compared to 2022. The company's yearly revenue for 2022 was $1.56B, representing an increase of 0.99% compared to 2021. IART's yearly revenue for 2021 was $1.54B, representing an increase of 12.43% compared to 2020.

Integra LifeSciences's quarterly revenue for Q2 2024 was $418.18M, a 13.37% increase from the previous quarter (Q1 2024), and a 9.68% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $368.87M, a -7.09% decrease from the previous quarter (Q4 2023), and a -3.14% decrease year-over-year (Q1 2023). IART's quarterly revenue for Q4 2023 was $397.04M, a 3.82% increase from the previous quarter (Q3 2023), and a -0.25% decrease year-over-year (Q4 2022).

Integra LifeSciences's revenue growth rate for the last 3 years (2021-2023) was -0.06%, and for the last 5 years (2019-2023) was 1.58%.

Integra LifeSciences's revenue streams in c 22 are Tissue Technologies, and Codman Specialty Surgical. Tissue Technologies generated $538.1M in revenue, accounting 34.55% of the company's total revenue, up 4.04% year-over-year. Codman Specialty Surgical generated $1.02B in revenue, accounting 65.45% of the company's total revenue, down -0.55% year-over-year.

For the fiscal year ending Dec 22, the largest source of revenue of Integra LifeSciences was Codman Specialty Surgical. This segment made a revenue of $1.02B, representing 65.45% of the company's total revenue.